Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Transfer Price Taxation System to Be Revised in FY2007
December 25, 2006
- Asahi Kasei Medical, Kuraray Medical to Integrate Businesses
December 25, 2006
- Tie-ups of Hansha Spreading to Kanto, Shikoku: Mr Eguchi
December 25, 2006
- MEDICAL DEVICE NEWS IN BRIEF
December 25, 2006
- Korosho Exchanges Opinions with NPhA on Generics, Distribution
December 25, 2006
- Financial Support to Be Provided to Fewer Patients with Ulcerative Colitis, Parkinson's Disease
December 25, 2006
- JGPMA Proposes "Drug Benefit Standard Price System"
December 25, 2006
- Reducing Number of "Cancer Refugees" Would Save \522.7 Billion
December 25, 2006
- SEMINAR
December 25, 2006
- No Increase in Resistance to Tamiflu Observed: Roche
December 25, 2006
- Biopharmaceuticals Expected to Show Strongest Growth in Future: JHSF Survey
December 25, 2006
- Allergic Rhinitis Affects QOL, Reduces Productivity: Prof. Okamoto
December 25, 2006
- NEW PRODUCTS
December 25, 2006
- Influenza Preventive Effects of Catechin Gargle Reported
December 25, 2006
- SURVEY 4 articles
December 25, 2006
- AstraZeneca to Simultaneously Start All PI Trials Worldwide
December 25, 2006
- SMO Group Holds CRC Training Seminar
December 25, 2006
- Sanofi-aventis to Start Large Epidemiological Study in Cerebral Infarction Patients
December 25, 2006
- Pazufloxacin Can Now Be Used as 1st-Choice Drug: Toyama, MPC
December 25, 2006
- Wyeth, Kyushu Univ. Moving Forward with Their R&D Alliance
December 25, 2006
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…